—Classifying myelodysplastic syndrome and secondary acute myeloid leukemia by genetic mutations rather than strictly by blast count may allow more patients to be eligible for AML and MDS clinical ...

Improvements in the classification of myelodysplastic syndrome, MDS, based on varying characteristics in the disease have better defined prognosis and helped patients and doctors make ...

Cytarabine with high-dose mitoxantrone induces rapid complete remissions in adult acute lymphoblastic leukemia without the use of vincristine or prednisone. To determine the treatment outcome of ...

Patient and disease characteristics of women with acute myelogenous leukemia (AML) and a history of breast cancer (BC). Background: Frequency of h-AML is 5%-7% among adult patients with AML. Most ...